Delano Ladd Sells 2,499 Shares of HealthEquity, Inc. (NASDAQ:HQY) Stock

HealthEquity, Inc. (NASDAQ:HQYGet Free Report) EVP Delano Ladd sold 2,499 shares of the company’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares of the company’s stock, valued at $3,999,680. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Delano Ladd also recently made the following trade(s):

  • On Monday, January 8th, Delano Ladd sold 2,586 shares of HealthEquity stock. The shares were sold at an average price of $70.00, for a total transaction of $181,020.00.

HealthEquity Stock Performance

HQY opened at $79.61 on Monday. HealthEquity, Inc. has a 52-week low of $48.86 and a 52-week high of $80.22. The company has a quick ratio of 4.93, a current ratio of 4.93 and a debt-to-equity ratio of 0.44. The company has a market cap of $6.83 billion, a P/E ratio of 234.15, a price-to-earnings-growth ratio of 1.34 and a beta of 0.55. The firm’s 50-day moving average price is $70.92 and its 200-day moving average price is $70.09.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its quarterly earnings data on Tuesday, December 5th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.32 by $0.08. HealthEquity had a net margin of 3.00% and a return on equity of 5.89%. The firm had revenue of $249.22 million for the quarter, compared to the consensus estimate of $243.63 million. As a group, equities analysts anticipate that HealthEquity, Inc. will post 1.48 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have commented on HQY. Barrington Research reissued an “outperform” rating and set a $85.00 price target on shares of HealthEquity in a research report on Monday, December 4th. JPMorgan Chase & Co. decreased their price target on shares of HealthEquity from $81.00 to $73.00 and set an “overweight” rating for the company in a research report on Friday, December 1st. Barclays began coverage on shares of HealthEquity in a research report on Wednesday, January 3rd. They set an “overweight” rating and a $84.00 price target for the company. Raymond James increased their price target on shares of HealthEquity from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, December 13th. Finally, Wells Fargo & Company increased their price target on shares of HealthEquity from $89.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 6th. One investment analyst has rated the stock with a hold rating and eight have given a buy rating to the stock. According to MarketBeat, HealthEquity has a consensus rating of “Moderate Buy” and an average price target of $83.25.

Check Out Our Latest Stock Analysis on HQY

Hedge Funds Weigh In On HealthEquity

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Franklin Resources Inc. increased its holdings in HealthEquity by 7.0% in the 4th quarter. Franklin Resources Inc. now owns 1,480,655 shares of the company’s stock worth $98,167,000 after buying an additional 96,583 shares during the period. Renaissance Group LLC acquired a new position in HealthEquity in the 4th quarter worth approximately $1,848,000. Trexquant Investment LP acquired a new stake in shares of HealthEquity during the 4th quarter worth approximately $4,980,000. Clearbridge Investments LLC grew its stake in shares of HealthEquity by 6.9% during the 4th quarter. Clearbridge Investments LLC now owns 2,357,572 shares of the company’s stock worth $156,307,000 after purchasing an additional 152,897 shares during the period. Finally, Wells Fargo & Company MN grew its stake in shares of HealthEquity by 1.4% during the 4th quarter. Wells Fargo & Company MN now owns 82,400 shares of the company’s stock worth $5,463,000 after purchasing an additional 1,145 shares during the period. Institutional investors and hedge funds own 98.46% of the company’s stock.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Insider Buying and Selling by Quarter for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.